Trial Profile
GnRHa Trigger in Asian Oocyte Donors Co-treated With a GnRH Antagonist - a Dose Finding Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 05 Nov 2015 New trial record
- 30 Oct 2015 Primary endpoint has not been met. (Number of mature oocytes), as per an article published in the Fertility and Sterility
- 30 Oct 2015 Results published in the Fertility and Sterility